Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Alzheimers Dement. 2019 Jul;15(7):907–916. doi: 10.1016/j.jalz.2019.04.005

Table 1.

Characteristics of participants in the UK Biobank included in the analyses.

Died
Alive at the End of Follow-Up Died During Follow-Up Total Dementia related death Other Cause of Death


N (%) 233,253 (96%) 9,705 (4%) 242,958 552 (6%) 9,153 (94%)
Baseline Age, mean (SD) 62.5 (3.8) 63.9 (3.8) 62.51 (3.8) 64.4 (3.6) 63.84 (3.8)
Years of follow up, median (SD) 7.67 (0.86) 4.89 (2.03) 7.58 (1.1) 5.65 (1.86) 4.84 (2.03)
Female N (%) 125,413 (54%) 3,653 (38%) 129,066 (53%) 209 (38%) 3,444 (38%)
APOE-e4, N (%) 60,724 (26%) 2641 (27%) 63,365 (26%) 204 (37%) 2,437 (27%)
AD GRS, mean (SD) 0.04 (0.40) 0.05 (0.41) 0.04 (.40) 0.16 (0.47) 0.04 (0.41)
AD GRS without APOE-e4, mean (SD) −0.14 (0.17) −0.14 (0.18) −0.14 (0.17) −0.12 (0.18) −0.14 (0.17)
Verbal Numeric Reasoning, mean (SD) 6.09 (2.07) 5.73 (2.05) 6.07 (2.07) 5.08 (2.06) 5.75 (2.05)
High education, N (%) 101,869(44%) 3,460 (36%) 105,329 (43%) 213 (39%) 3,347 (35%)
Any Hospitalization 159,511 (68%) 8,145 (84%) 167,656 (69%) 466 (84%) 7679 (84%)
Hospitalization due to falls 11,147 (5%) 1,004 (10%) 12,151 (5%) 105 (19%) 1004 (10%)
Hospitalization due to UTIs 7,658 (3%) 1,462 (15%) 9,120 (4%) 150 (27%) 1462 (15%)